1. Home
  2. ABCL vs CNNE Comparison

ABCL vs CNNE Comparison

Compare ABCL & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • CNNE
  • Stock Information
  • Founded
  • ABCL 2012
  • CNNE 2014
  • Country
  • ABCL Canada
  • CNNE United States
  • Employees
  • ABCL N/A
  • CNNE N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • CNNE Restaurants
  • Sector
  • ABCL Health Care
  • CNNE Consumer Discretionary
  • Exchange
  • ABCL Nasdaq
  • CNNE Nasdaq
  • Market Cap
  • ABCL 1.1B
  • CNNE 1.1B
  • IPO Year
  • ABCL 2020
  • CNNE N/A
  • Fundamental
  • Price
  • ABCL $4.72
  • CNNE $19.54
  • Analyst Decision
  • ABCL Strong Buy
  • CNNE Buy
  • Analyst Count
  • ABCL 5
  • CNNE 3
  • Target Price
  • ABCL $8.00
  • CNNE $23.33
  • AVG Volume (30 Days)
  • ABCL 3.7M
  • CNNE 697.0K
  • Earning Date
  • ABCL 11-03-2025
  • CNNE 11-11-2025
  • Dividend Yield
  • ABCL N/A
  • CNNE 3.08%
  • EPS Growth
  • ABCL N/A
  • CNNE N/A
  • EPS
  • ABCL N/A
  • CNNE N/A
  • Revenue
  • ABCL $32,875,999.00
  • CNNE $437,200,000.00
  • Revenue This Year
  • ABCL $16.99
  • CNNE N/A
  • Revenue Next Year
  • ABCL $63.73
  • CNNE N/A
  • P/E Ratio
  • ABCL N/A
  • CNNE N/A
  • Revenue Growth
  • ABCL N/A
  • CNNE N/A
  • 52 Week Low
  • ABCL $1.89
  • CNNE $15.92
  • 52 Week High
  • ABCL $5.82
  • CNNE $22.36
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 58.52
  • CNNE 57.36
  • Support Level
  • ABCL $4.32
  • CNNE $18.85
  • Resistance Level
  • ABCL $4.85
  • CNNE $19.44
  • Average True Range (ATR)
  • ABCL 0.28
  • CNNE 0.43
  • MACD
  • ABCL 0.05
  • CNNE 0.17
  • Stochastic Oscillator
  • ABCL 87.25
  • CNNE 78.27

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About CNNE Cannae Holdings Inc.

Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.

Share on Social Networks: